Steve Paul reignites xanomeline research as Karuna CEOKaruna aims to overcome safety concerns with combination therapy Share XSteve Paul reignites xanomeline research as Karuna CEOhttps://pharmaphorum.com/news/steve-paul-reignites-xanomeline-research/
Wellcome Trust awards $8m cash injection to trial schizophrenia drugThe Wellcome Trust has awarded $8 million to PureTech’s Karuna to take its schizophrenia drug into mid-stage trials. Share XWellcome Trust awards $8m cash injection to trial schizophrenia drughttps://pharmaphorum.com/news/wellcome-trust-awards-trial-schizophrenia-drug/